PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Wuling Motors Holdings Limited (0305.HK)
0.700.02 (-2.78%)
0.68 - 0.75
0.33 - 0.86
12.91M / 4.66M (Avg.)
35.00 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-3.84%
Negative revenue growth while 0425.HK stands at 24.02%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
17.03%
Gross profit growth at 50-75% of 0425.HK's 25.21%. Martin Whitman would question if cost structure or brand is lagging.
39.17%
EBIT growth above 1.5x 0425.HK's 23.71%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
39.17%
Operating income growth above 1.5x 0425.HK's 23.71%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
12.12%
Net income growth comparable to 0425.HK's 11.53%. Walter Schloss might see both following similar market or cost trajectories.
13.73%
EPS growth 1.25-1.5x 0425.HK's 9.72%. Bruce Berkowitz would check if strategic initiatives like cost cutting or better capital management explain the difference.
13.73%
Diluted EPS growth 1.25-1.5x 0425.HK's 9.72%. Bruce Berkowitz would verify if strategic moves (e.g., targeted acquisitions, cost cuts) explain the edge.
-1.45%
Share reduction while 0425.HK is at 2.17%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-1.36%
Reduced diluted shares while 0425.HK is at 2.12%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
-140.53%
Negative OCF growth while 0425.HK is at 1.98%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-128.18%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
48403.57%
10Y revenue/share CAGR above 1.5x 0425.HK's 687.02%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
21.62%
5Y revenue/share CAGR under 50% of 0425.HK's 126.63%. Michael Burry would suspect a significant competitive gap or product weakness.
2.09%
3Y revenue/share CAGR under 50% of 0425.HK's 64.37%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
-54872.48%
Negative 10Y OCF/share CAGR while 0425.HK stands at 433.46%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-12824.71%
Negative 5Y OCF/share CAGR while 0425.HK is at 114.72%. Joel Greenblatt would question the firm’s operational model or cost structure.
-708.35%
Negative 3Y OCF/share CAGR while 0425.HK stands at 137.61%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
231.68%
Net income/share CAGR at 50-75% of 0425.HK's 376.48%. Martin Whitman might question if the firm’s product or cost base lags behind.
3699.57%
5Y net income/share CAGR above 1.5x 0425.HK's 90.68%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
574.70%
3Y net income/share CAGR above 1.5x 0425.HK's 84.14%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
96.16%
5Y equity/share CAGR 1.25-1.5x 0425.HK's 64.14%. Bruce Berkowitz confirms if reinvested profits or buybacks explain the superior buildup.
39.07%
3Y equity/share CAGR similar to 0425.HK's 36.36%. Walter Schloss sees both having parallel profitability or reinvestment over 3 years.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both lowered dividends mid-term. Martin Whitman might suspect broad sector constraints or strategic shifts from dividends.
No Data
No Data available this quarter, please select a different quarter.
-23.04%
Firm’s AR is declining while 0425.HK shows 34.10%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
15.68%
Inventory growth well above 0425.HK's 22.41%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-13.03%
Negative asset growth while 0425.HK invests at 14.27%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
7.65%
Similar to 0425.HK's 7.78%. Walter Schloss finds parallel capital usage or profit distribution strategies.
2122.61%
Debt growth far above 0425.HK's 1.49%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-25.80%
Our R&D shrinks while 0425.HK invests at 24.56%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
25.32%
SG&A growth well above 0425.HK's 28.13%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.